drugset / Trial / NCT00432055

Effects of Botulinum Toxin Type A in Adults With Cerebral Palsy

NCT00432055 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this project is to investigate if there is a significant difference in active joint range of motion, questionnaire on gait function and health related quality of life between patients randomized to treatment with Botulinum toxin type A and patients randomized to placebo treatment.

Timeline

Start
2007-01
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic — Intramuscular

Indications